Literature DB >> 3677119

Dacarbazine, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma: a phase II study.

S Gundersen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3677119

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Reduction of the local toxicity of intraperitoneal chemotherapy; an experimental model.

Authors:  R G Molloy; B Crowley; K T Moran; M P Brady
Journal:  Ir J Med Sci       Date:  1990-06       Impact factor: 1.568

2.  Follow up of soluble IL-2 receptor level in metastatic malignant melanoma patients treated by chemoimmunotherapy.

Authors:  C Soubrane; R Mouawad; M Ichen; J Suissa; C Borel; E Vuillemin; A Benhammouda; J P Bizzari; M Weil; D Khayat
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

Review 3.  [Therapy of malignant melanoma at the stage of distant metastasis].

Authors:  C Garbe; T K Eigentler
Journal:  Hautarzt       Date:  2004-02       Impact factor: 0.751
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.